Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Inozyme Pharma Inc.

    NASDAQ: INZY · Real-Time Price · USD
    4.00
    0.00 (0.00%)
    At close: Jun 30, 2025, 3:59 PM

    Inozyme Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 1.29M 1.18M 1.05M
    Gross Profit
    		 n/a -1.29M -1.18M -1.05M
    Operating Income
    		 -104.03M -75.64M -68.67M -56.65M
    Interest Income
    		 7.67M 7.84M 1.93M 211K
    Pretax Income
    		 -102.02M -71.17M -67.06M -56.62M
    Net Income
    		 -102.02M -71.17M -65.45M -56.41M
    Selling & General & Admin
    		 20.8M 20.8M 20.83M 18.93M
    Research & Development
    		 83.23M 54.05M 47.85M 37.72M
    Other Expenses
    		 n/a n/a -319K -189K
    Operating Expenses
    		 104.03M 75.64M 68.67M 56.65M
    Interest Expense
    		 -5.56M 3.33M n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 75.64M 68.67M 56.65M
    Income Tax Expense
    		 n/a n/a -1.61M -211K
    Shares Outstanding (Basic)
    		 62.81M 51.84M 37.76M 23.56M
    Shares Outstanding (Diluted)
    		 62.81M 51.84M 37.76M 23.56M
    EPS (Basic)
    		 -1.62 -1.37 -1.73 -2.39
    EPS (Diluted)
    		 -1.62 -1.37 -1.73 -2.39
    EBITDA
    		 -104.03M -74.81M -65.88M -55.97M
    EBIT
    		 -107.58M -75.64M -68.67M -56.62M
    Depreciation & Amortization
    		 3.55M 833K 1.18M 1.05M

    Add to Watchlist